$1.53B
$384 Million
0.05% of portfolio
18,365
Q2 2025
Reduced 1.7%
-
$382 Million
0.05% of portfolio
-
Q1 2025
New
-
$370 Million
0.05% of portfolio
-
Q1 2025
Reduced 15.46%
$51.4B
$387 Million
0.05% of portfolio
2,876
Q2 2025
Reduced 0.72%
$3.47B
$400 Million
0.05% of portfolio
25,000
Q2 2024
Reduced 16.67%
$6.6B
$409 Million
0.05% of portfolio
840
Q2 2025
Reduced 4.55%
$173B
$357 Million
0.05% of portfolio
2,242
Q2 2025
Added 1.45%
$2.36B
$355 Million
0.05% of portfolio
2,266
Q2 2025
Added 13.24%
$8.53B
$421 Million
0.05% of portfolio
31,300
Q2 2025
Added 10.21%
-
$409 Million
0.05% of portfolio
-
Q1 2025
Added 3.19%
$1.46B
$376 Million
0.05% of portfolio
12,612
Q2 2025
Added 21.36%
$0
$415 Million
0.05% of portfolio
6,580
Q4 2024
Added 90.17%
$8.26B
$356 Million
0.05% of portfolio
24,900
Q1 2025
Reduced 6.04%
$0
$412 Million
0.05% of portfolio
2,107
Q2 2025
New
-
$405 Million
0.05% of portfolio
-
Q2 2024
New
$2.73B
$386 Million
0.05% of portfolio
21,504
Q2 2025
Added 12.65%
$218B
$421 Million
0.05% of portfolio
1,084
Q2 2025
Reduced 8.06%
Brightspring Health Svcs Inc
-
$382 Million
0.05% of portfolio
-
Q1 2025
New
$3.02B
$361 Million
0.05% of portfolio
25,350
Q4 2024
Added 27.77%
$55B
$356 Million
0.05% of portfolio
4,870
Q2 2025
Reduced 7.83%
$0
$390 Million
0.05% of portfolio
5,239
Q2 2025
Added 55.28%
$0
$402 Million
0.05% of portfolio
10,595
Q2 2025
New
$0
$428 Million
0.05% of portfolio
6,694
Q2 2025
Added 0.65%
$4.22B
$421 Million
0.05% of portfolio
17,500
Q2 2025
Reduced 9.33%
$35.6B
$423 Million
0.05% of portfolio
5,425
Q2 2025
Reduced 8.44%
$1.87B
$419 Million
0.05% of portfolio
23,763
Q2 2025
Added 9.27%
$1.11B
$416 Million
0.05% of portfolio
9,946
Q4 2024
Added 5.29%
$8.04B
$400 Million
0.05% of portfolio
4,066
Q3 2024
Reduced 2.4%
Halozyme Therapeutics Inc
-
$361 Million
0.05% of portfolio
-
Q2 2025
Reduced 9.94%
$5.28B
$426 Million
0.05% of portfolio
15,555
Q2 2025
Added 7.48%
$4.99B
$428 Million
0.05% of portfolio
11,286
Q2 2025
Added 5.24%
-
$428 Million
0.05% of portfolio
-
Q2 2025
Reduced 18.52%
$99.2B
$386 Million
0.05% of portfolio
1,400
Q2 2025
Added 24.67%
$45.1B
$300 Million
0.04% of portfolio
2,328
Q2 2025
Added 0.09%
$4.97B
$296 Million
0.04% of portfolio
3,000
Q2 2024
Reduced 25.0%
$29.2B
$316 Million
0.04% of portfolio
27,536
Q1 2025
Added 9.79%
$2.68B
$309 Million
0.04% of portfolio
18,000
Q2 2025
Reduced 5.26%
$70.9B
$280 Million
0.04% of portfolio
3,082
Q2 2025
Reduced 0.87%
$1.64B
$348 Million
0.04% of portfolio
23,476
Q2 2025
Reduced 1.79%
$65.4B
$285 Million
0.04% of portfolio
2,703
Q2 2025
Added 2.74%
-
$330 Million
0.04% of portfolio
-
Q2 2024
Added 87.75%
$994M
$276 Million
0.04% of portfolio
14,352
Q2 2025
New
-
$343 Million
0.04% of portfolio
-
Q1 2025
New
Ventas Rlty LTD Partnership
-
$347 Million
0.04% of portfolio
-
Q4 2024
Reduced 40.21%
$16.4B
$279 Million
0.04% of portfolio
4,830
Q2 2025
Added 4.32%
$119B
$303 Million
0.04% of portfolio
1,272
Q2 2025
Added 1.68%
$1.25B
$278 Million
0.04% of portfolio
9,246
Q3 2024
Added 80.06%
$5.18B
$290 Million
0.04% of portfolio
8,923
Q2 2025
Added 3.41%
-
$283 Million
0.04% of portfolio
-
Q3 2024
New
$19.3B
$289 Million
0.04% of portfolio
3,642
Q2 2025
Added 10.16%